COLUMBIA, Md., Sept. 4 /PRNewswire-FirstCall/ -- Martek's life'sDHA(TM) from microalgae is effective in reducing the level of triglycerides in male hypertriglyceridemic patients, according to a study published in the current issue of The American Journal of Clinical Nutrition. In this study DHA (docosahexaenoic acid) alone was effective, without EPA (eicosapentaenoic acid), the other omega 3 commonly found in fish oil, in reducing triglycerides. Hypertriglyceridemia (high triglyceride levels) in men is associated with an increased risk of cardiovascular disease and metabolic syndrome.
The study, a randomized, parallel, double blind, placebo-controlled study that included 34 subjects, showed that supplementation with 3 grams DHA per day for 45 days resulted in a 24% decrease in fasting and postprandial triglyceride levels. This effect continued throughout the 90-day study period. Although LDL cholesterol increased by 13 percent, significant improvement was seen in the distribution of lipoprotein particle size. Researchers concluded that "DHA supplementation may improve cardiovascular health by lowering concentrations of triacylglycerols and small, dense LDL particles." The investigators used an EPA-free algal oil source of DHA, supplied by Martek. The study, authored by Dr. D. Kelly and associates, was conducted through the University of California Davis, Veterans Affairs of Northern California Health Care System and the US Department of Agriculture. Martek also contributed a portion of the funding for the study.
"The body of research supporting the health benefits of DHA for brain, eye and heart health throughout the lifecycle continues to grow," said Steve Dubin, CEO of Martek Biosciences.
Martek's life'sDHA(TM) is a vegetarian form of DHA omega-3, a long
chain omega-3 fatty acid that serves as a primary building block for the
brain and the eye and supports brain, eye and cardiovascular health
throughout life. There is a large and growing b
'/>"/>
| SOURCE Martek Copyright©2007 PR Newswire. All rights reserved |